• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD must make a difficult decision on whether to keep or stop taking ADHD medication during pregnancy and breast-feeding. There aren't enough data on how exposure to ADHD for a long time could affect the fetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus don't develop neurological developmental conditions like hearing or vision impairment seizures, febrile seizures, or IQ impairment. The authors acknowledge that further high-quality studies are needed.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication need to evaluate the benefits of using it against the possible dangers for the foetus. The doctors don't have the information to give clear advice, but can provide information on the risks and benefits to assist pregnant women to make an informed decision.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during their early pregnancy did not have a higher risk of fetal malformations or structural birth defects. Researchers conducted a large population-based study of case control to assess the frequency of major structural defects in infants born to mothers who took stimulants during pregnancy. Pediatric cardiologists and clinical geneticists looked over the counter adhd medication uk the cases to ensure correct case classification and to minimize the possibility of bias.

The research conducted by the researchers was not without its limitations. The researchers were unable in the beginning, to separate the effects triggered by the medication from the disorder. That limitation makes it difficult to know whether the small associations observed in the exposed groups result from medication use or confounding by comorbidities. In addition the study did not study long-term offspring outcomes.

The study revealed that infants whose mothers had taken ADHD medication during pregnancy had a slightly greater risk of being admitted to the neonatal care unit (NICU) as compared to those whose mothers did not use any medication during pregnancy or stopped taking their medication before or during pregnancy. The reason for this was central nervous system-related disorders and the increased risk for admission did not appear to be influenced by which stimulant medications were used during pregnancy.

Women who used stimulant ADHD medication during pregnancy were also at an increased risk of having a caesarean delivery or having a baby born with an low Apgar score (less than 7). These increases didn't seem to be influenced by the type of medication that was used during pregnancy.

The research suggests that the small risk associated with the use of ADHD medications during early pregnancy may be offset by the greater benefit for both mother and child of continued treatment for the woman's condition. Physicians should discuss this with their patients and, where possible, help them develop strategies to improve coping skills which can reduce the negative impact of her condition on her daily functioning and relationships.

Interactions with Medication

As more women than ever are diagnosed with ADHD and treated with medication, the issue of whether or not to discontinue treatment during pregnancy is one that more and more physicians confront. Most of the time, these decisions are made without clear and authoritative evidence in either case, which means that doctors must weigh their knowledge, the experiences of other doctors, and what the research suggests on the subject, along with their best judgment for each patient.

The issue of possible risks for infants can be extremely difficult. Many studies on this issue are based on observational evidence rather than controlled research, and their findings are often contradictory. Additionally, the majority of studies limit their analysis to live births, which may underestimate the severity of teratogenic effects that could cause abortion or termination of the pregnancy. The study discussed in the journal club addresses these limitations by analyzing information on deceased and live births.

The conclusion is that while some studies have shown that there is a positive correlation between ADHD medications and the possibility of certain birth defects, other studies have found no such relationship, and most studies have a neutral or slightly negative impact. In each case, a careful study of the risks and benefits must be performed.

For a lot of women with adhd medication private prescription, the decision to discontinue medication can be difficult, if not impossible. In an article published in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can lead to increased depression, feelings of loneliness and family conflict for those suffering from the disorder. A loss of medication may affect the ability to safely drive and perform work-related tasks, which are crucial aspects of daily life for those suffering from ADHD.

She suggests that women who are not sure whether to continue taking the medication or stop due to pregnancy, educate their family members, coworkers and their friends about the condition, its impact on daily functioning and the benefits of keeping the current treatment plan. In addition, educating them can aid in ensuring that the woman feels supported in her struggle with her decision. Certain medications can be passed through the placenta. If a patient decides to not take her ADHD medication while pregnant and breastfeeding, it is crucial to be aware that the medication may be transferred to her baby.

Birth Defects and Risk of

As the use types of adhd medication uk ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) grows there are concerns about the effects that the drugs might have on fetuses. A study that was published in the journal Molecular Psychiatry adds to the existing knowledge about this subject. Using two massive data sets researchers were able to analyze more than 4.3 million pregnancies to determine whether stimulant medication use increased the risk of birth defects. Although the risk overall remains low, the researchers did find that first-trimester exposure to ADHD medications was associated with an increased risk of certain heart defects such as ventriculo-septal defect (VSD).

The researchers of the study found no link between the use of early medications and other congenital anomalies, like facial clefting, or club foot. The findings are in line with previous studies showing a small but significant increase in the risk of cardiac malformations in women who started taking ADHD medications before pregnancy. This risk increased in the latter half of pregnancy, when many women are forced to stop taking their ADHD medication.

Women who were taking ADHD medication in the first trimester were more likely require a caesarean birth, have an insufficient Apgar after birth and have a baby that needed breathing assistance after birth. However, the authors of the study were unable to eliminate selection bias by restricting the study to women who didn't have any other medical issues that could have contributed to these findings.

Researchers hope that their research will inform physicians when they encounter pregnant women. The researchers recommend that, while discussing the risks and benefits are crucial, the decision on whether to continue or stop medication should be made based on the severity of each woman's ADHD symptoms and the needs of the woman.

The authors warn that, even though stopping the medication is an option to look into, it is not recommended due to the high rate depression and other mental disorders for women who are pregnant or recently gave birth. Research has also shown that women who stop taking their medications will have a harder adjustment to life without them after the baby is born.

Nursing

It can be overwhelming becoming a mother. Women with ADHD who have to deal with their symptoms while attending physician appointments and making preparations for the arrival of a baby and adjusting to new household routines can experience severe challenges. This is why many women elect to continue taking their ADHD medications throughout the course of pregnancy.

The risk for breastfeeding infant is not too high since the majority of stimulant medication is absorbed through breast milk at a low level. The rate of exposure to medication can vary depending upon the dosage and frequency of administration as well as the time of the day. Additionally, different drugs enter the infant's system through the gastrointestinal tract, or through breast milk. The impact on the health of a newborn isn't fully understood.

Some physicians may discontinue stimulant medication during a woman’s pregnancy due to the lack of research. This is a difficult decision for the patient, who must weigh the benefits of continuing her medication against the possible risks to the embryo. In the meantime, until more information is available, doctors should inquire with all pregnant patients about their experience with ADHD and whether they are taking or planning to take medication during the perinatal time.

Numerous studies have demonstrated that women can continue taking their adhd medication pregnancy (https://iampsychiatry05697.blogs100.Com) medication in a safe manner during pregnancy and breast-feeding. As a result, more and more patients choose to do so and in consultation with their doctor they have found that the benefits of continuing their current medication outweigh any risks.

Women with ADHD who are planning to nurse should seek the advice of an expert psychiatrist prior to becoming pregnant. They should review their medications with their doctor and discuss the advantages and disadvantages of continued treatment, including non-pharmacological strategies. Psychoeducation is also required to help pregnant women with ADHD understand the symptoms and the underlying disorder. They should also be educated about treatment options and build coping mechanisms. This should involve a multidisciplinary approach, which includes the GP, obstetricians and psychiatry. Pregnancy counseling should include a discussion of a treatment plan for the mother as well as the child, and monitoring for indicators of deterioration, and, if necessary, adjustments to the medication regimen.